The Journal of Organic Chemistry
Article
equiv, 5.2 mmol, 2.48 g) and the solution was stirred until
homogeneous (approx. 15 min). To the stirred solution, Pd(PPh3)4
(0.05 equiv, 0.026 mmol, 30 mg) and CuI (0.1 equiv, 0.052 mmol, 9.9
mg) were then added. The head space of the reaction vessel was
purged with argon and the flask was sealed with a glass stopper. After
stirring for 5 h at room temperature, dry silica was added. The mixture
was then concentrated onto the silica gel using rotoevaporation and
the resulting white powder was used to dry load a silica gel column.
Normal-phase silica gel flash chromatography (40 g silica column,
hexane with a 10−50% gradient of EtOAc over 18 min) gave a
head space of the vial was purged with argon, and the vessel was
sealed with a screw on cap. After stirring at room temperature
overnight, the reaction mixture was transferred to a round-bottom
flask and diluted with DCM (approx. 50 mL). Silica gel was added to
the vessel and the crude reaction mixture was concentrated onto the
silica gel. Silica gel flash chromatography (hexane with a 30−100%
gradient of EtOAc, each with 0.5% AcOH) gave the pure product (75
mg, 0.13 mmol, 45%) as a colorless oil. 1H NMR (400 MHz, CDCl3):
δ 9.94 (s, 1H), 8.06 (s, 1H), 8.01 (s, 1H), 7.91 (s, 1H), 7.88 (s, 1H),
7.82 (s, 1H), 7.67 (s, 1H), 4.51−4.43 (m, 2H), 3.86−3.78 (m, 2H),
3.71−3.64 (m, 2H), 3.59−3.52 (m, 2H), 3.36 (s, 3H), 2.54 (t, J = 7.3
Hz, 2H), 2.50 (t, J = 6.9 Hz, 2H), 1.92 (tt, J = 7.3, 6.9 Hz, 2H), 0.24
(s, 9H); 13C{1H} NMR (100 MHz, CDCl3): δ 190.6, 178.4, 165.1,
139.9, 138.3, 136.5, 132.8, 132.5, 132.0, 131.8, 130.7, 124.8, 124.6,
124.1, 123.0, 102.3, 97.2, 90.8, 89.6, 88.2, 79.8, 71.8, 70.4, 69.1, 64.4,
59.0, 32.7, 23.3, 18.7, −0.3 (3C). HRMS (ESI) m/z: [M + Na]+ calcd
for C32H34O7SiNa, 581.1966; found, 581.1982.
6-(3-((3-Ethynyl-5-formylphenyl)ethynyl)-5-((2-(2-
methoxyethoxy)ethoxy)carbonyl)phenyl)hex-5-ynoic Acid (CBH).
To a 20 mL scintillation vial, TBAF·3H2O (0.28 mmol, 88 mg)
was added and dissolved in dry degassed THF stabilized with 250
ppm BHT. To this solution, BHT (0.28 mmol, 62 mg) and AcOH
(0.28 mmol, 16 μL) were added. In a separate vial equipped with a
stir bar, CBTMS (75 mg, 0.13 mmol) was dissolved in dry degassed
THF stabilized with 250 ppm BHT (2.8 mL). The TBAF solution
was then added to the CBTMS solution. The head space was purged
with argon and the mixture was stirred at room temperature. After 5
min, the reaction was quenched by adding ice (approx. 5 g). After
stirring for 1 min, silica (approx. 1 g) was added and the reaction
mixture was concentrated in vacuo. Silica gel flash chromatography
(hexane with a 30−100% gradient of EtOAc, each with 0.5% AcOH)
gave the pure product (53 mg, 0.11 mmol, 85% yield) as a colorless
oil which solidified to a white amorphous solid on refrigeration
overnight. 1H NMR (400 MHz, CDCl3): δ 9.99 (s, 1H), 8.11 (s, 1H),
8.06 (s, 1H), 7.99 (s, 1H), 7.95 (s, 1H), 7.87 (s, 1H), 7.71 (s, 1H),
4.54−4.46 (m, 2H), 3.89−3.82 (m, 2H), 3.74−3.68 (m, 2H), 3.62−
3.56 (m, 2H), 3.40 (s, 3H), 3.20 (s, 1H), 2.58 (t, J = 7.2 Hz, 2H),
2.54 (t, J = 6.9 Hz, 2H), 1.96 (tt, J = 7.2, 6.9 Hz, 2H); 13C{1H} NMR
(100 MHz, CDCl3): δ 193.1, 181.1, 167.8, 142.7, 141.1, 139.3, 135.5,
135.3, 135.2, 134.5, 133.4, 127.3, 126.9, 126.5, 125.6, 93.5, 92.5, 90.8,
83.9, 82.5, 82.3, 74.5, 73.1, 71.8, 67.1, 61.7, 35.4, 26.0, 21.4. HRMS
(ESI) m/z: [M + Na] calcd for C29H26O7Na, 509.1571; found,
509.1605.
CBBH. The resin (100 mg with 95 μmol/g loading) functionalized
with CBBH was cleaved and purified according to the procedure
outlined above, and CBBH (7.4 mg, 8.6 μmol, 90% yield) was afforded
as a white solid. 1H NMR (400 MHz, CDCl3): δ 10.03 (s, 1H), 10.01
(s, 1H), 8.26−8.17 (overlap, 2H), 8.13 (t, J = 1.6 Hz, 1H), 8.07 (t, J =
1.7 Hz, 1H), 8.04−7.99 (overlap, 3H), 7.97 (t, J = 1.6 Hz, 1H), 7.95
(t, J = 1.7 Hz, 1H), 7.91−7.87 (overlap, 2H), 7.74 (t, J = 1.7 Hz, 1H),
4.60−4.45 (overlap, 4H), 3.94−3.81 (overlap, 4H), 3.78−3.67
(overlap, 4H), 3.65−3.54 (overlap, 4H), 3.41 (s, 3H), 3.41 (s, 3H),
3.22 (s, 1H), 2.59 (t, J = 7.3 Hz, 2H), 2.55 (t, J = 7.0 Hz, 2H), 1.97
(tt, J = 7.3, 7.0 Hz, 2H). HRMS (ESI) m/z: [M + Na]+ calcd for
C52H44O12Na, 883.2725; found, 883.2879.
CBAH. The resin (20 mg with 100 μmol/g resin loading)
functionalized with CBAH was cleaved and purified according to the
procedure outlined above, and CBAH (1.2 mg, 1.4 μmol, 71% yield)
was afforded as a white solid. 1H NMR (400 MHz, CDCl3 with 0.5%
TFA and 0.1% H2O): δ 10.00 (s, 1H), 8.20 (s, 1H), 8.16 (s, 1H), 8.10
(s, 1H), 8.06−8.00 (overlap, 3H), 7.97 (s, 1H), 7.90 (s, 1H), 7.76 (s,
1H), 7.74 (s, 1H), 7.53 (s, 1H), 7.48 (s, 1H), 4.63−4.47 (overlap,
4H), 3.97−3.86 (overlap, 4H), 3.84−3.75 (overlap, 4H), 3.75−3.68
(overlap, 4H), 3.48 (s, 3H), 3.47 (s, 3H), 3.26 (s, 1H), 2.64 (t, J = 7.3
Hz, 2H), 2.55 (t, J = 6.8 Hz, 2H), 1.98 (tt, J = 7.3, 6.8 Hz, 2H).
HRMS (ESI) m/z: [M + Na] calcd for C51H45NO11Na, 870.2885;
found, 870.2859.
mixture of product ATMS and 3. The mixture of the product and
I
reactant was concentrated to a light yellow oil and then subjected to a
C18 reverse-phase flash column (50 g column loaded using 5 mL
DMF, then run with water and a 50−100% ACN gradient over 5 min,
followed by 100% ACN for 10 min). The reverse-phase column
afforded pure 3 (eluted from 85 to 90% ACN, 4.63 mmol, 2.21 g, 99%
recovery) as a white solid and desired product IATMS (Rf = 5 min with
100% ACN, 295 mg, 0.52 mmol, 99% yield) as a waxy solid. 1H NMR
(400 MHz, CDCl3): δ 8.32 (s, 1H), 8.12 (s, 1H), 8.00 (s, 1H), 7.06
(s, 1H), 6.77 (s, 2H), 4.53−4.46 (m, 2H), 3.86−3.82 (m, 2H), 3.76−
3.66 (overlap, 4H), 3.61−3.55 (m, 2H), 3.40 (s, 3H), 0.24 (s, 9H);
13C{1H} NMR (100 MHz, CDCl3): δ 164.3, 146.3, 143.9, 137.9,
131.8, 131.7, 125.5, 125.3, 124.1, 123.1, 118.5, 117.8, 104.2, 94.3,
93.2, 91.0, 86.4, 71.8, 70.5, 69.0, 64.5, 59.0, −0.2 (3C). HRMS (ESI)
m/z: [M + Na]+ calcd for C25H28INO4SiNa, 584.0724; found,
584.0746.
2-(2-Methoxyethoxy)ethyl 3-((3-formyl-5-((trimethylsilyl)-
ethynyl)phenyl)ethynyl)-5-iodobenzoate (IBTMS). To a 200 mL
round-bottom flask equipped with a stir bar, 2b (165 mg, 0.73
mmol) was added and then dissolved in anhydrous toluene (7.3 mL)
and DIPEA (3 equiv 2.19 mmol, 384 μL). Diiodide 3 was added (10
equiv, 7.3 mmol, 3.49 g) and the solution was stirred until
homogeneous (approx. 15 min). To the stirred solution, Pd(PPh3)4
(0.05 equiv, 0.037 mmol, 42 mg) and CuI (0.1 equiv, 0.073 mmol,
13.9 mg) were then added. The head space of the reaction vessel was
purged with argon and the flask was sealed with a glass stopper. After
stirring for 2.5 h at room temperature, dry silica was added. The
mixture was then concentrated onto the silica gel using rotoevapora-
tion and the resulting white powder was used to dry load a silica gel
column. Normal-phase silica gel flash chromatography (40 g silica
column, hexane with a 10−50% gradient of EtOAc over 18 min) gave
a mixture of product BTMS and 3. The mixture of the product and
I
reactant was concentrated to a light yellow oil and then subjected to a
C18 reverse-phase flash column (50 g column loaded using 5 mL
DMF, then run with water and a 50−100% ACN gradient over 5 min,
followed by 100% ACN for 10 min). The reverse-phase column
afforded pure 3 (eluted from 85 to 90% ACN, 6.24 mmol, 2.97 g, 95%
recovery) as a white solid and desired product IBTMS (Rf = 5 min with
100% ACN, 418 mg, 0.73 mmol, 99% yield) as a waxy solid. 1H NMR
(400 MHz, CDCl3): δ 9.98 (s, 1H), 8.37 (t, J = 1.6 Hz, 1H), 8.16 (t, J
= 1.6 Hz, 1H), 8.05 (t, J = 1.6 Hz, 1H), 7.95 (t, J = 1.6 Hz, 1H), 7.93
(t, J = 1.6 Hz, 1H), 7.86 (t, J = 1.6 Hz, 1H), 4.53−4.48 (m, 2H),
3.88−3.82 (m, 2H), 3.73−3.68 (m, 2H), 3.61−3.56 (m, 2H), 3.40 (s,
3H), 0.27 (s, 9H); 13C{1H} NMR (100 MHz, CDCl3): δ 190.2,
164.0, 143.8, 139.7, 138.4, 136.4, 132.6, 131.83, 131.80, 131.77, 124.7,
124.4, 123.7, 102.2, 97.2, 93.2, 89.0, 88.5, 71.7, 70.4, 68.9, 64.5, 58.9,
−0.4 (3C). HRMS (ESI) m/z: [M + Na]+ calcd for C26H27IO5SiNa,
597.0565; found, 597.0582.
6-(3-((3-Formyl-5-((trimethylsilyl)ethynyl)phenyl)ethynyl)-5-((2-
(2-methoxyethoxy) ethoxy)carbonyl)phenyl)hex-5-ynoic Acid
(CBTMS). To a 20 mL scintillation vial, AsPh3 (0.12 mmol, 37.2 mg)
and Pd2(dba)3 (0.015 mmol, 14 mg) were added and dissolved in
anhydrous DCE (1 mL). The head space of the vial was purged with
argon and then the vial was sealed with a screw on cap. The purple
solution was gently swirled until the Pd2(dba)3 dissolved and the
color changed to bright yellow (approx. 10 min). In a separate vial
equipped with a stir bar, IBTMS (175 mg, 0.30 mmol) was dissolved in
anhydrous DCE (1 mL). To this solution, DIPEA (1 mL) and 5-
hexynoic acid (0.46 mmol, 50 μL) were added. While stirring, a
portion of the catalyst solution was added dropwise (0.6 mL). The
CBBBH. The resin (100 mg with 88 μmol/g resin loading)
functionalized with CBBBH was cleaved and purified according to
the procedure outlined above, and CBBBH (9.0 mg, 7.3 μmol, 83%
H
J. Org. Chem. XXXX, XXX, XXX−XXX